Inventor · disambiguated record
Hui Lei
Also filed as: LEI HUI
18 granted patents·20 pending applications·46 citations·filing 2004–2025
91Inventor score
Top patents by PatentIndex Score
38 records- 0194US11926626B2Heterocyclic GLP-1 agonistsGASHERBRUM BIO INC·Filed 2022·Granted Mar 12, 2024·7 cites·23 claims
- 0294US11492365B2Heterocyclic GLP-1 agonistsGASHERBRUM BIO INC·Filed 2022·Granted Nov 8, 2022·6 cites·15 claims
- 0393US12221442B2Heterocyclic GLP-1 agonistsGASHERBRUM BIO INC·Filed 2024·Granted Feb 11, 2025·3 cites·4 claims
- 0492US12291529B2Heterocyclic GLP-1 agonistsGASHERBRUM BIO INC·Filed 2024·Granted May 6, 2025·2 cites·28 claims
- 0592US11897851B2Heterocyclic GLP-1 agonistsGASHERBRUM BIO INC·Filed 2023·Granted Feb 13, 2024·3 cites·5 claims
- 0688US11884627B2Compounds and compositions for treating conditions associated with LPA receptor activityLHOTSE BIO INC·Filed 2023·Granted Jan 30, 2024·1 cites·34 claims
- 0782US2025115606A1Heterocyclic glp-1 agonistsGASHERBRUM BIO INC·Filed 2024·Application pending·0 cites
- 0877US7335632B2Beta-secretase inhibitors and methods of use thereofCOMENTIS INC·Filed 2004·Granted Feb 26, 2008·14 cites·25 claims
- 0976US7504420B2Compounds which inhibit beta-secretase activity and methods of useCOMENTIS INC·Filed 2006·Granted Mar 17, 2009·5 cites·48 claims
- 1075US2023071840A1Heterocyclic glp-1 agonistsGASHERBRUM BIO INC·Filed 2022·Application pending·0 cites
- 1174US7659289B2Hydroxyethylene-based β-secretase inhibitors and use thereofCOMENTIS INC·Filed 2005·Granted Feb 9, 2010·3 cites·56 claims
- 1274US2024327404A1Heterocyclic glp-1 agonistsGASHERBRUM BIO INC·Filed 2024·Application pending·0 cites
- 1372US12428375B2Compounds and compositions for treating conditions associated with LPA receptor activityLHOTSE BIO INC·Filed 2023·Granted Sep 30, 2025·0 cites·15 claims
- 1471US11926643B2Heterocyclic GLP-1 agonistsGASHERBRUM BIO INC·Filed 2022·Granted Mar 12, 2024·0 cites·20 claims
- 1568US8299267B2(3-hydroxy-4-amino-butan-2-yl) -3- (2-thiazol-2-yl-pyrrolidine-1-carbonyl) benzamide derivatives and related compounds as beta-secretase inhibitors for treatingGHOSH ARUN K·Filed 2008·Granted Oct 30, 2012·2 cites·52 claims
- 1665US2025019389A1Heterocyclic agonistsGASHERBRUM BIO INC·Filed 2024·Application pending·0 cites
- 1762US12486269B2Compounds and compositions for treating conditions associated with calcitonin receptor and/or amylin receptor activityACONCAGUA BIO INC·Filed 2025·Granted Dec 2, 2025·0 cites·26 claims
- 1861US2023295154A1Heterocyclic glp-1 agonistsGASHERBRUM BIO INC·Filed 2021·Application pending·0 cites
- 1960US2025206757A15,8-dihydro-1,7-naphthyridine derivatives as glp-1 agonists for the treatment of diabetesGASHERBRUM BIO INC·Filed 2023·Application pending·0 cites
- 2060US2025109148A1Heterocyclic glp-1 agonistsGASHERBRUM BIO INC·Filed 2023·Application pending·0 cites
- 2159US2025382306A1Heterocyclic compound as taar1 ligand agonistShandong luye pharmaceutical co ltd·Filed 2023·Application pending·0 cites
- 2259US2025042916A1Compounds, compositions, and methodsACONCAGUA BIO INC·Filed 2024·Application pending·0 cites
- 2359US2013102593A1Pyrrolidine compounds which inhibit beta-secretase activity and methods of use thereofBILCER GEOFFREY M·Filed 2009·Application pending·0 cites
- 2458US2024366639A1Heterocyclic glp-1 agonistsGASHERBRUM BIO INC·Filed 2022·Application pending·0 cites
- 2558US2025051355A1Compounds, compositions, and methodsACONCAGUA BIO INC·Filed 2024·Application pending·0 cites
- 2654US2024400562A1Compounds and compositions for treating conditions associated with lpa receptor activityLHOTSE BIO INC·Filed 2022·Application pending·0 cites
- 2753US2023322771A1Heterocyclic glp-1 agonistsGASHERBRUM BIO INC·Filed 2021·Application pending·0 cites
- 2851US2024018102A1Compounds and compositions for treating conditions associated with lpa receptor activityLHOTSE BIO INC·Filed 2021·Application pending·0 cites
- 2949US11117891B2Isoquinolin and naphthydrin compoundsLILLY CO ELI·Filed 2018·Granted Sep 14, 2021·0 cites·8 claims
- 3049US2012295894A1Pyrrolidine compounds which inhibit beta-secretase activity and methods of use thereofBILCER GEOFFREY M·Filed 2011·Application pending·0 cites
- 3149US2008176939A1Compounds which inhibit beta-secretase activity and methods of use thereofCOMENTIS INC·Filed 2007·Application pending·0 cites
- 3246US2012214802A1Pyrrolidine compounds which inhibit beta-secretase activity and methods of use thereofBILCER GEOFFREY M·Filed 2009·Application pending·0 cites
- 3343US2010286145A1Isophthalamide derivatives inhibiting beta-secretase activityCOMENTIS INC·Filed 2008·Application pending·0 cites
- 3440US10005731B2Modulators of the retinoid-related orphan receptor gamma (ROR-gamma) for use in the treatment of autoimmune and inflammatory diseasesGLAXO GROUP LTD·Filed 2013·Granted Jun 26, 2018·0 cites·19 claims
- 3540US2008207527A1Bicyclic Compounds Which Inhibit Beta-Secretase Activity and Methods of Use ThereofCOMENTIS INC·Filed 2005·Application pending·0 cites
- 3635US9868724B2CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Jan 16, 2018·0 cites·21 claims
- 3734US9902715B2CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Feb 27, 2018·0 cites·21 claims
- 3828US9902735B2Heteroaryl substituted compounds as RORγ inhibitorsGLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPEMENT LTD·Filed 2015·Granted Feb 27, 2018·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Hui Lei files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →